Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.
about
MiR-206 Suppresses the Progression of Coronary Artery Disease by Modulating Vascular Endothelial Growth Factor (VEGF) Expression.A Case of Chronic Total Occlusion of the Left Anterior Descending Artery Successfully Treated with Side Branch Technique Using the Soutenir CVPreserved endothelial progenitor cell angiogenic activity in African American essential hypertensive patients.
P2860
Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy.
@ast
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy.
@en
type
label
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy.
@ast
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy.
@en
prefLabel
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy.
@ast
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy.
@en
P2093
P2860
P356
P1476
Serum VEGF Predicts Worse Clin ...... Coronary Intervention Therapy
@en
P2093
Jiamin Niu
Zengtang Zhang
Zhiqiang Zhang
P2860
P304
P356
10.12659/MSM.894803
P577
2015-10-26T00:00:00Z